- Release Date: 27/06/23 15:46
- Summary: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK
- Price Sensitive: Yes
- Download Document 116.52KB
Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.9¢ |
Change
0.001(1.14%) |
Mkt cap ! $80.23M | |||
| Open | High | Low | Value | Volume |
| 8.8¢ | 8.9¢ | 8.8¢ | $5.243K | 59.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31582 | 8.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.9¢ | 71453 | 2 |
View Market Depth
| Last trade - 10.28am 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
8.8¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 8.8¢ | 8.8¢ | 8.8¢ | 4550 | ||
| Last updated 11.22am 18/06/2024 ? | |||||
| PER (ASX) Chart |
